Microdosing GLP-1s for longevity and glucose control
The speakers argued that microdosing GLP-1 receptor agonists improves glucose tolerance and may offer broader long-term health benefits.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.